This study exists to understand whether ketamine treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether ketamine treatment can better prevent setbacks and support longer-term stability.

In United States

BipolarityDrugFrom 6 Years to 12 Years

Countries: United States
Sponsor: Juvenile Bipolar Research Foundation
Condition: Bipolarity

View study

UnknownNCT04071600

Intranasal Neuropeptide Y in study in Level Two Trauma Patients for PTSD and Acute Stress Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: New York Medical College
Condition: PTSD

View study

CompletedNCT03878316

Intranasal Oxytocin for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition: Addiction

View study

CompletedNCT01908205

Intranasal Oxytocin for Children and Adolescents With Autism Spectrum Disorders (ASD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 10 Years to 17 Years

Countries: United States, Canada
Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Condition: Anxiety

View study

WithdrawnNCT06784180

Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in people with Addiction Taking Buprenorphine

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrug

Countries: United States
Sponsor: University of North Carolina, Chapel Hill
Condition: Addiction

View study

CompletedNCT01281969

Intravenous Immunoglobulin for PANDAS

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCD, AnxietyDrugFrom 4 Years to 13 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: OCD, Anxiety

View study

TerminatedNCT01371110

Intravenous Ketamine in the Treatment of OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Wayne Goodman MD
Condition: OCD

View study

CompletedNCT05031611

Intuitive Eating for Disordered Eating

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

Eating disordersBehavioralFrom 18 Years to 30 Years

Countries: United States
Sponsor: Yeshiva University
Condition: Eating disorders

View study

CompletedNCT02048241

Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder

This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

In United States

ADHDBehavioralFrom 6 Years to 12 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: ADHD

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.